{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T15:26:47Z","timestamp":1789658807415,"version":"4.0.1"},"reference-count":157,"publisher":"Georg Thieme Verlag KG","funder":[{"name":"Bundesministerium f\u00fcr Forschung und Technologie","award":["EXC 3118\/1\u2014project number 533770413"],"award-info":[{"award-number":["EXC 3118\/1\u2014project number 533770413"]}]},{"name":"Deutsche Forschungsgemeinschaft","award":["403224013 and 535081457"],"award-info":[{"award-number":["403224013 and 535081457"]}],"id":[{"id":"https:\/\/ror.org\/018mejw64","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Semin Liver Dis"],"abstract":"<jats:p>Metabolic dysfunction-associated steatohepatitis is a consequence of pathological hepatocellular lipid accumulation where lipotoxic stress triggers chronic inflammation. Liver macrophages are important regulators in the transition from simple steatosis to steatohepatitis and progression toward fibrosis, cirrhosis, and hepatocellular carcinoma. In this process, the hepatic macrophage pool undergoes a significant transformation with loss of embryonic Kupffer cells (KCs) and infiltration of diverse subsets of monocyte-derived macrophages, including monocytic KCs and lipid-associated macrophages (LAMs). Emerging evidence supports macrophage infiltration and the emergence of LAMs as primary adaptive responses aimed at restoring tissue homeostasis by mitigating lipotoxic stress, clearing cell death signals, and promoting the resolution of steatohepatitis and fibrosis regression. Chronic exposure of LAMs to lipotoxic and inflammatory conditions, however, induces inflammatory and fibrogenic programs that drive steatohepatitis and fibrosis progression. In conclusion, these context-dependent roles of liver macrophage subsets have important therapeutic implications, supporting approaches to shift macrophages toward tissue-restoring responses.<\/jats:p>","DOI":"10.1055\/a-2954-5433","type":"journal-article","created":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T22:58:39Z","timestamp":1789513119000},"source":"Crossref","is-referenced-by-count":0,"title":["Context-Dependent Roles of Liver Macrophages in MASH"],"prefix":"10.1055","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8755-7703","authenticated-orcid":false,"given":"Paul","family":"Horn","sequence":"additional","affiliation":[{"name":"Charit\u00e9 University Hospital Berlin, Germany","place":["Berlin"],"department":["Department of Hepatology and Gastroenterology, Campus Virchow-Klinikum (CVK) and Campus Charit\u00e9 Mitte (CCM)"]},{"name":"Charit\u00e9 University Hospital Berlin, Germany","place":["Berlin"],"department":["Berlin Institute of Health at Charit\u00e9, BIH Biomedical Innovation Academy, BIH Charit\u00e9 Digital Clinician Scientist Program"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6206-0226","authenticated-orcid":false,"given":"Frank","family":"Tacke","sequence":"additional","affiliation":[{"name":"Charit\u00e9 University Hospital Berlin, Germany","place":["Berlin"],"department":["Department of Hepatology and Gastroenterology, Campus Virchow-Klinikum (CVK) and Campus Charit\u00e9 Mitte (CCM)"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2026,9,15]]},"reference":[{"issue":"18","key":"ref1","doi-asserted-by":"crossref","first-page":"e186420","DOI":"10.1172\/JCI186420","article-title":"MASH: the nexus of metabolism, inflammation, and fibrosis","volume":"135","author":"G R Steinberg","year":"2025","journal-title":"J Clin Invest"},{"issue":"18","key":"ref2","doi-asserted-by":"crossref","first-page":"e198334","DOI":"10.1172\/JCI198334","article-title":"The pathogenesis of hepatic steatosis in MASLD: a lipid droplet perspective","volume":"135","author":"N Krahmer","year":"2025","journal-title":"J Clin Invest"},{"issue":"10","key":"ref3","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/S2468-1253(24)00193-6","article-title":"Natural history and progression of metabolic dysfunction-associated steatotic liver disease","volume":"9","author":"H Hagstr\u00f6m","year":"2024","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"05","key":"ref4","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.jhep.2025.12.026","article-title":"Is liver steatosis a disease or the emperor's new clothes?","volume":"84","author":"A Krag","year":"2026","journal-title":"J Hepatol"},{"issue":"S 01","key":"ref5","first-page":"S10","article-title":"Pathogenesis of MASLD and MASH - role of insulin resistance and lipotoxicity","volume":"59","author":"S K Bansal","year":"2024","journal-title":"Aliment Pharmacol Ther"},{"issue":"10","key":"ref6","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/s41575-023-00807-x","article-title":"Hepatic inflammatory responses in liver fibrosis","volume":"20","author":"L Hammerich","year":"2023","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1053\/j.gastro.2025.03.010","article-title":"Regulation of hepatic stellate cell phenotypes in MASH","volume":"169","author":"T Kisseleva","year":"2025","journal-title":"Gastroenterology"},{"issue":"04","key":"ref8","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/j.jhep.2022.06.012","article-title":"Immune mechanisms linking metabolic injury to inflammation and fibrosis in fatty liver disease - novel insights into cellular communication circuits","volume":"77","author":"M Peiseler","year":"2022","journal-title":"J Hepatol"},{"issue":"02","key":"ref9","doi-asserted-by":"crossref","first-page":"sxaf072","DOI":"10.1093\/stmcls\/sxaf072","article-title":"Macrophage heterogeneity and plasticity in liver injury and repair mechanisms","volume":"44","author":"T Zhang","year":"2026","journal-title":"Stem Cells"},{"issue":"11","key":"ref10","doi-asserted-by":"crossref","first-page":"101196","DOI":"10.1016\/j.jhepr.2024.101196","article-title":"Understanding the complex macrophage landscape in MASLD","volume":"6","author":"F F De Ponti","year":"2024","journal-title":"JHEP Rep"},{"issue":"01","key":"ref11","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41423-020-00558-8","article-title":"Hepatic macrophages in liver homeostasis and diseases-diversity, plasticity and therapeutic opportunities","volume":"18","author":"Y Wen","year":"2021","journal-title":"Cell Mol Immunol"},{"issue":"06","key":"ref12","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1002\/hep.27985","article-title":"Plasma cholesteryl ester transfer protein is predominantly derived from Kupffer cells","volume":"62","author":"Y Wang","year":"2015","journal-title":"Hepatology"},{"issue":"01","key":"ref13","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/hep.27793","article-title":"Liver inflammation abrogates immunological tolerance induced by Kupffer cells","volume":"62","author":"F Heymann","year":"2015","journal-title":"Hepatology"},{"issue":"01","key":"ref14","doi-asserted-by":"crossref","first-page":"10321","DOI":"10.1038\/ncomms10321","article-title":"Bone marrow-derived monocytes give rise to self-renewing and fully differentiated Kupffer cells","volume":"7","author":"C L Scott","year":"2016","journal-title":"Nat Commun"},{"issue":"01","key":"ref15","doi-asserted-by":"crossref","first-page":"4383","DOI":"10.1038\/s41467-018-06318-7","article-title":"Single cell RNA sequencing of human liver reveals distinct intrahepatic macrophage populations","volume":"9","author":"S A MacParland","year":"2018","journal-title":"Nat Commun"},{"issue":"7768","key":"ref16","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/s41586-019-1373-2","article-title":"A human liver cell atlas reveals heterogeneity and epithelial progenitors","volume":"572","author":"N Aizarani","year":"2019","journal-title":"Nature"},{"issue":"02","key":"ref17","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.cell.2021.12.018","article-title":"Spatial proteogenomics reveals distinct and evolutionarily conserved hepatic macrophage niches","volume":"185","author":"M Guilliams","year":"2022","journal-title":"Cell"},{"issue":"7783","key":"ref18","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/s41586-019-1631-3","article-title":"Resolving the fibrotic niche of human liver cirrhosis at single-cell level","volume":"575","author":"P Ramachandran","year":"2019","journal-title":"Nature"},{"issue":"02","key":"ref19","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/HEP.0000000000000557","article-title":"Osteopontin characterizes bile duct-associated macrophages and correlates with liver fibrosis severity in primary sclerosing cholangitis","volume":"79","author":"K De Muynck","year":"2024","journal-title":"Hepatology"},{"issue":"07","key":"ref20","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1038\/s41590-025-02190-y","article-title":"Neuroprotective liver portal area macrophages attenuate hepatic inflammation","volume":"26","author":"M Xu","year":"2025","journal-title":"Nat Immunol"},{"issue":"02","key":"ref21","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.immuni.2017.07.018","article-title":"A liver capsular network of monocyte-derived macrophages restricts hepatic dissemination of intraperitoneal bacteria by neutrophil recruitment","volume":"47","author":"F Sierro","year":"2017","journal-title":"Immunity"},{"issue":"05","key":"ref22","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1053\/jhep.2003.50472","article-title":"Kupffer cell engulfment of apoptotic bodies stimulates death ligand and cytokine expression","volume":"38","author":"A Canbay","year":"2003","journal-title":"Hepatology"},{"issue":"03","key":"ref23","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1172\/JCI83885","article-title":"Hepatocyte mitochondrial DNA drives nonalcoholic steatohepatitis by activation of TLR9","volume":"126","author":"I Garcia-Martinez","year":"2016","journal-title":"J Clin Invest"},{"issue":"01","key":"ref24","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/hep4.1801","article-title":"Role of cholesterol-associated steatohepatitis in the development of NASH","volume":"6","author":"C L Horn","year":"2022","journal-title":"Hepatol Commun"},{"issue":"16","key":"ref25","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1042\/CS20160838","article-title":"TLR9 is up-regulated in human and murine NASH: pivotal role in inflammatory recruitment and cell survival","volume":"131","author":"A R Mridha","year":"2017","journal-title":"Clin Sci (Lond)"},{"issue":"01","key":"ref26","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jhep.2012.02.028","article-title":"Toxic lipids stored by Kupffer cells correlates with their pro-inflammatory phenotype at an early stage of steatohepatitis","volume":"57","author":"A Leroux","year":"2012","journal-title":"J Hepatol"},{"issue":"02","key":"ref27","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jhep.2017.11.014","article-title":"Lipotoxicity and the gut-liver axis in NASH pathogenesis","volume":"68","author":"F Marra","year":"2018","journal-title":"J Hepatol"},{"issue":"02","key":"ref28","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1172\/JCI121842","article-title":"STING-mediated inflammation in Kupffer cells contributes to progression of nonalcoholic steatohepatitis","volume":"129","author":"Y Yu","year":"2019","journal-title":"J Clin Invest"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.3389\/fimmu.2018.02418","article-title":"Adapted immune responses of myeloid-derived cells in fatty liver disease","volume":"9","author":"J Hundertmark","year":"2018","journal-title":"Front Immunol"},{"issue":"05","key":"ref30","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.jhep.2017.01.022","article-title":"NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice","volume":"66","author":"A R Mridha","year":"2017","journal-title":"J Hepatol"},{"issue":"01","key":"ref31","doi-asserted-by":"crossref","first-page":"2331460","DOI":"10.1080\/19490976.2024.2331460","article-title":"Breaking the barriers: the role of gut homeostasis in metabolic-associated steatotic liver disease (MASLD)","volume":"16","author":"R Bened\u00e9-Ubieto","year":"2024","journal-title":"Gut Microbes"},{"issue":"06","key":"ref32","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.immuni.2020.04.001","article-title":"Niche-specific reprogramming of epigenetic landscapes drives myeloid cell diversity in nonalcoholic steatohepatitis","volume":"52","author":"J S Seidman","year":"2020","journal-title":"Immunity"},{"issue":"02","key":"ref33","doi-asserted-by":"crossref","first-page":"108626","DOI":"10.1016\/j.celrep.2020.108626","article-title":"Dynamic shifts in the composition of resident and recruited macrophages influence tissue remodeling in NASH","volume":"34","author":"S Daemen","year":"2021","journal-title":"Cell Rep"},{"issue":"815","key":"ref34","doi-asserted-by":"crossref","first-page":"eadv2106","DOI":"10.1126\/scitranslmed.adv2106","article-title":"Impaired TIM4-mediated efferocytosis by liver macrophages contributes to fibrosis in metabolic dysfunction-associated steatohepatitis","volume":"17","author":"H Shi","year":"2025","journal-title":"Sci Transl Med"},{"issue":"03","key":"ref35","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.immuni.2020.06.003","article-title":"Impaired Kupffer cell self-renewal alters the liver response to lipid overload during non-alcoholic steatohepatitis","volume":"53","author":"S Tran","year":"2020","journal-title":"Immunity"},{"issue":"03","key":"ref36","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.molcel.2019.07.028","article-title":"Landscape of intercellular crosstalk in healthy and NASH liver revealed by single-cell secretome gene analysis","volume":"75","author":"X Xiong","year":"2019","journal-title":"Mol Cell"},{"issue":"03","key":"ref37","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.immuni.2020.08.004","article-title":"Osteopontin expression identifies a subset of recruited macrophages distinct from Kupffer cells in the fatty liver","volume":"53","author":"A Remmerie","year":"2020","journal-title":"Immunity"},{"issue":"82","key":"ref38","doi-asserted-by":"crossref","first-page":"eadd8945","DOI":"10.1126\/sciimmunol.add8945","article-title":"Identification of a broadly fibrogenic macrophage subset induced by type 3 inflammation","volume":"8","author":"T Fabre","year":"2023","journal-title":"Sci Immunol"},{"issue":"03","key":"ref39","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.cell.2019.05.054","article-title":"Lipid-associated macrophages control metabolic homeostasis in a trem2-dependent manner","volume":"178","author":"D A Jaitin","year":"2019","journal-title":"Cell"},{"issue":"10","key":"ref40","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1038\/s41591-019-0590-4","article-title":"Single-cell immune landscape of human atherosclerotic plaques","volume":"25","author":"D M Fernandez","year":"2019","journal-title":"Nat Med"},{"issue":"03","key":"ref41","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/imcb.12616","article-title":"Hepatic TREM2+ macrophages express matrix metalloproteinases to control fibrotic scar formation","volume":"101","author":"K J Lee","year":"2023","journal-title":"Immunol Cell Biol"},{"issue":"02","key":"ref42","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.immuni.2025.01.002","article-title":"Spatially restricted and ontogenically distinct hepatic macrophages are required for tissue repair","volume":"58","author":"F F De Ponti","year":"2025","journal-title":"Immunity"},{"issue":"08","key":"ref43","doi-asserted-by":"crossref","first-page":"100756","DOI":"10.1016\/j.jhepr.2023.100756","article-title":"Saturated fatty acid-enriched small extracellular vesicles mediate a crosstalk inducing liver inflammation and hepatocyte insulin resistance","volume":"5","author":"I Garcia-Martinez","year":"2023","journal-title":"JHEP Rep"},{"issue":"11","key":"ref44","doi-asserted-by":"crossref","first-page":"100877","DOI":"10.1016\/j.jhepr.2023.100877","article-title":"Steatosis drives monocyte-derived macrophage accumulation in human metabolic dysfunction-associated fatty liver disease","volume":"5","author":"M M Chan","year":"2023","journal-title":"JHEP Rep"},{"issue":"04","key":"ref45","doi-asserted-by":"crossref","first-page":"916","DOI":"10.2337\/db09-1403","article-title":"C-C chemokine receptor 2 (CCR2) regulates the hepatic recruitment of myeloid cells that promote obesity-induced hepatic steatosis","volume":"59","author":"A E Obstfeld","year":"2010","journal-title":"Diabetes"},{"issue":"04","key":"ref46","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1002\/hep.29544","article-title":"Therapeutic inhibition of inflammatory monocyte recruitment reduces steatohepatitis and liver fibrosis","volume":"67","author":"O Krenkel","year":"2018","journal-title":"Hepatology"},{"issue":"02","key":"ref47","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1194\/jlr.M063412","article-title":"Hepatocytes release ceramide-enriched pro-inflammatory extracellular vesicles in an IRE1\u03b1-dependent manner","volume":"57","author":"E Kakazu","year":"2016","journal-title":"J Lipid Res"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"2980","DOI":"10.3389\/fimmu.2018.02980","article-title":"Hepatocyte-derived lipotoxic extracellular vesicle sphingosine 1-phosphate induces macrophage chemotaxis","volume":"9","author":"C Y Liao","year":"2018","journal-title":"Front Immunol"},{"issue":"02","key":"ref49","doi-asserted-by":"crossref","first-page":"e0613","DOI":"10.1097\/HC9.0000000000000613","article-title":"Deletion of sphingosine 1-phosphate receptor 1 in myeloid cells reduces hepatic inflammatory macrophages and attenuates MASH","volume":"9","author":"G Parthasarathy","year":"2025","journal-title":"Hepatol Commun"},{"issue":"01","key":"ref50","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1186\/s12964-024-01720-9","article-title":"Role of liver sinusoidal endothelial cell in metabolic dysfunction-associated fatty liver disease","volume":"22","author":"Q He","year":"2024","journal-title":"Cell Commun Signal"},{"issue":"06","key":"ref51","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.jhep.2019.07.019","article-title":"Integrin \u03b21-enriched extracellular vesicles mediate monocyte adhesion and promote liver inflammation in murine NASH","volume":"71","author":"Q Guo","year":"2019","journal-title":"J Hepatol"},{"issue":"12","key":"ref52","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1172\/JCI200319246","article-title":"Obesity is associated with macrophage accumulation in adipose tissue","volume":"112","author":"S P Weisberg","year":"2003","journal-title":"J Clin Invest"},{"issue":"12","key":"ref53","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1172\/JCI200319451","article-title":"Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance","volume":"112","author":"H Xu","year":"2003","journal-title":"J Clin Invest"},{"issue":"06","key":"ref54","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"D E Kleiner","year":"2005","journal-title":"Hepatology"},{"issue":"05","key":"ref55","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1194\/jlr.M034876","article-title":"Hepatic cholesterol crystals and crown-like structures distinguish NASH from simple steatosis","volume":"54","author":"G N Ioannou","year":"2013","journal-title":"J Lipid Res"},{"issue":"02","key":"ref56","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1194\/jlr.M053785","article-title":"Cholesterol-lowering drugs cause dissolution of cholesterol crystals and disperse Kupffer cell crown-like structures during resolution of NASH","volume":"56","author":"G N Ioannou","year":"2015","journal-title":"J Lipid Res"},{"issue":"12","key":"ref57","doi-asserted-by":"crossref","first-page":"e82163","DOI":"10.1371\/journal.pone.0082163","article-title":"Hepatic crown-like structure: a unique histological feature in non-alcoholic steatohepatitis in mice and humans","volume":"8","author":"M Itoh","year":"2013","journal-title":"PLoS One"},{"issue":"22","key":"ref58","doi-asserted-by":"crossref","first-page":"e92902","DOI":"10.1172\/jci.insight.92902","article-title":"CD11c+ resident macrophages drive hepatocyte death-triggered liver fibrosis in a murine model of nonalcoholic steatohepatitis","volume":"2","author":"M Itoh","year":"2017","journal-title":"JCI Insight"},{"issue":"04","key":"ref59","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1097\/HEP.0000000000001429","article-title":"MIF-mediated crosstalk between THRSP + hepatocytes and CD74 + lipid-associated macrophages in hepatic periportal zone drives MASH","volume":"83","author":"X Xu","year":"2026","journal-title":"Hepatology"},{"issue":"06","key":"ref60","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1194\/jlr.M072454","article-title":"Cholesterol crystallization within hepatocyte lipid droplets and its role in murine NASH","volume":"58","author":"G N Ioannou","year":"2017","journal-title":"J Lipid Res"},{"issue":"07","key":"ref61","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1053\/j.gastro.2019.12.054","article-title":"Adipose tissue-liver cross talk in the control of whole-body metabolism: implications in nonalcoholic fatty liver disease","volume":"158","author":"V Azzu","year":"2020","journal-title":"Gastroenterology"},{"issue":"05","key":"ref62","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1097\/HEP.0000000000000638","article-title":"The macrophage STING-YAP axis controls hepatic steatosis by promoting the autophagic degradation of lipid droplets","volume":"80","author":"T Yang","year":"2024","journal-title":"Hepatology"},{"issue":"03","key":"ref63","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1172\/JCI134165","article-title":"Insulin resistance drives hepatic de novo lipogenesis in nonalcoholic fatty liver disease","volume":"130","author":"G I Smith","year":"2020","journal-title":"J Clin Invest"},{"issue":"02","key":"ref64","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1002\/hep.23337","article-title":"Kupffer cells promote hepatic steatosis via interleukin-1\u03b2-dependent suppression of peroxisome proliferator-activated receptor \u03b1 activity","volume":"51","author":"R Stienstra","year":"2010","journal-title":"Hepatology"},{"issue":"02","key":"ref65","doi-asserted-by":"crossref","first-page":"347","DOI":"10.2337\/db09-0016","article-title":"Depletion of liver Kupffer cells prevents the development of diet-induced hepatic steatosis and insulin resistance","volume":"59","author":"W Huang","year":"2010","journal-title":"Diabetes"},{"issue":"03","key":"ref66","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1097\/HEP.0000000000000918","article-title":"Kupffer cell diversity maintains liver function in alcohol-associated liver disease","volume":"81","author":"K Sasaki","year":"2025","journal-title":"Hepatology"},{"issue":"8077","key":"ref67","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1038\/s41586-025-09190-w","article-title":"Kupffer cell programming by maternal obesity triggers fatty liver disease","volume":"644","author":"H Huang","year":"2025","journal-title":"Nature"},{"issue":"04","key":"ref68","doi-asserted-by":"crossref","first-page":"101745","DOI":"10.1016\/j.jhepr.2026.101745","article-title":"CD36-PPAR\u03b3-SPP1 axis mediates hepatocyte-macrophage coordination to drive MASLD-related liver fibrosis","volume":"8","author":"Z Dai","year":"2026","journal-title":"JHEP Rep"},{"issue":"03","key":"ref69","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/s12276-023-00965-7","article-title":"Molecular mechanisms of mitochondrial DNA release and activation of the cGAS-STING pathway","volume":"55","author":"J Kim","year":"2023","journal-title":"Exp Mol Med"},{"issue":"14","key":"ref70","doi-asserted-by":"crossref","first-page":"e2100225118","DOI":"10.1073\/pnas.2100225118","article-title":"TBK1 recruitment to STING activates both IRF3 and NF-\u03baB that mediate immune defense against tumors and viral infections","volume":"118","author":"S Yum","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"ref71","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/s41574-019-0256-9","article-title":"The regulation of hepatic fatty acid synthesis and partitioning: the effect of nutritional state","volume":"15","author":"L Hodson","year":"2019","journal-title":"Nat Rev Endocrinol"},{"issue":"21","key":"ref72","doi-asserted-by":"crossref","first-page":"e190635","DOI":"10.1172\/JCI190635","article-title":"Adipocyte death promotes hepatic infiltration of S100A8+ macrophages and steatotic liver disease progression in mice","volume":"135","author":"Y Guan","year":"2025","journal-title":"J Clin Invest"},{"issue":"01","key":"ref73","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.immuni.2022.11.013","article-title":"Prolonged hypernutrition impairs TREM2-dependent efferocytosis to license chronic liver inflammation and NASH development","volume":"56","author":"X Wang","year":"2023","journal-title":"Immunity"},{"issue":"11","key":"ref74","doi-asserted-by":"crossref","first-page":"e0265","DOI":"10.1097\/HC9.0000000000000265","article-title":"sTREM2 is a plasma biomarker for human NASH and promotes hepatocyte lipid accumulation","volume":"7","author":"V Kothari","year":"2023","journal-title":"Hepatol Commun"},{"issue":"06","key":"ref75","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1038\/s42255-023-00801-2","article-title":"Itaconic acid underpins hepatocyte lipid metabolism in non-alcoholic fatty liver disease in male mice","volume":"5","author":"J M Weiss","year":"2023","journal-title":"Nat Metab"},{"issue":"04","key":"ref76","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1002\/hep.31582","article-title":"Osteopontin takes center stage in chronic liver disease","volume":"73","author":"Z Song","year":"2021","journal-title":"Hepatology"},{"issue":"01","key":"ref77","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/hepr.12166","article-title":"Osteopontin: versatile modulator of liver diseases","volume":"44","author":"S Nagoshi","year":"2014","journal-title":"Hepatol Res"},{"issue":"02","key":"ref78","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1002\/hep.24701","article-title":"Osteopontin, an oxidant stress sensitive cytokine, up-regulates collagen-I via integrin \u03b1(V)\u03b2(3) engagement and PI3K\/pAkt\/NF\u03baB signaling","volume":"55","author":"R Urtasun","year":"2012","journal-title":"Hepatology"},{"issue":"04","key":"ref79","doi-asserted-by":"crossref","first-page":"e16131","DOI":"10.1111\/liv.16131","article-title":"Osteopontin promotes cholangiocyte secretion of chemokines to support macrophage recruitment and fibrosis in MASH","volume":"45","author":"J D Coombes","year":"2025","journal-title":"Liver Int"},{"issue":"07","key":"ref80","doi-asserted-by":"crossref","first-page":"e166731","DOI":"10.1172\/JCI166731","article-title":"Hepatocyte-specific CCAAT\/enhancer binding protein \u03b1 restricts liver fibrosis progression","volume":"134","author":"T Yan","year":"2024","journal-title":"J Clin Invest"},{"issue":"03","key":"ref81","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1002\/hep.25758","article-title":"Osteopontin is a novel downstream target of SOX9 with diagnostic implications for progression of liver fibrosis in humans","volume":"56","author":"J Pritchett","year":"2012","journal-title":"Hepatology"},{"issue":"08","key":"ref82","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1007\/s00125-011-2170-0","article-title":"Osteopontin deficiency protects against obesity-induced hepatic steatosis and attenuates glucose production in mice","volume":"54","author":"F W Kiefer","year":"2011","journal-title":"Diabetologia"},{"issue":"01","key":"ref83","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1053\/j.gastro.2023.03.228","article-title":"Macrophage-derived osteopontin (SPP1) protects from nonalcoholic steatohepatitis","volume":"165","author":"H Han","year":"2023","journal-title":"Gastroenterology"},{"issue":"33","key":"ref84","doi-asserted-by":"crossref","first-page":"8800","DOI":"10.1073\/pnas.1705365114","article-title":"Mouse macrophages show different requirements for phosphatidylserine receptor Tim4 in efferocytosis","volume":"114","author":"Y Yanagihashi","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"764","key":"ref85","doi-asserted-by":"crossref","first-page":"eadi0284","DOI":"10.1126\/scitranslmed.adi0284","article-title":"HIF-2\u03b1 drives hepatic Kupffer cell death and proinflammatory recruited macrophage activation in nonalcoholic steatohepatitis","volume":"16","author":"I Jeelani","year":"2024","journal-title":"Sci Transl Med"},{"issue":"08","key":"ref86","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1016\/j.cmet.2024.05.008","article-title":"Reactive oxygen species regulation by NCF1 governs ferroptosis susceptibility of Kupffer cells to MASH","volume":"36","author":"J Zhang","year":"2024","journal-title":"Cell Metab"},{"issue":"12","key":"ref87","first-page":"e0853","article-title":"Induction of TFEB promotes Kupffer cell survival and reduces lipid accumulation in MASLD","volume":"9","author":"M M Chan","year":"2025","journal-title":"Hepatol Commun"},{"issue":"04","key":"ref88","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.jhep.2016.05.037","article-title":"Bone marrow-derived and resident liver macrophages display unique transcriptomic signatures but similar biological functions","volume":"65","author":"L Beattie","year":"2016","journal-title":"J Hepatol"},{"issue":"04","key":"ref89","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.immuni.2019.08.017","article-title":"Stellate cells, hepatocytes, and endothelial cells imprint the Kupffer cell identity on monocytes colonizing the liver macrophage niche","volume":"51","author":"J Bonnardel","year":"2019","journal-title":"Immunity"},{"issue":"09","key":"ref90","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1016\/j.immuni.2021.08.006","article-title":"A subset of Kupffer cells regulates metabolism through the expression of CD36","volume":"54","author":"C Bl\u00e9riot","year":"2021","journal-title":"Immunity"},{"issue":"09","key":"ref91","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1016\/j.immuni.2021.05.005","article-title":"Identification of a Kupffer cell subset capable of reverting the T cell dysfunction induced by hepatocellular priming","volume":"54","author":"G De Simone","year":"2021","journal-title":"Immunity"},{"issue":"01","key":"ref92","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1172\/JCI200522675","article-title":"Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair","volume":"115","author":"J S Duffield","year":"2005","journal-title":"J Clin Invest"},{"issue":"11","key":"ref93","doi-asserted-by":"crossref","first-page":"G1310","DOI":"10.1152\/ajpgi.00365.2011","article-title":"Hepatic recruitment of macrophages promotes nonalcoholic steatohepatitis through CCR2","volume":"302","author":"K Miura","year":"2012","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"06","key":"ref94","doi-asserted-by":"crossref","first-page":"e0158156","DOI":"10.1371\/journal.pone.0158156","article-title":"Antifibrotic effects of the dual CCR2\/CCR5 antagonist cenicriviroc in animal models of liver and kidney fibrosis","volume":"11","author":"E Lefebvre","year":"2016","journal-title":"PLoS One"},{"issue":"01","key":"ref95","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/hep.22950","article-title":"Hepatic recruitment of the inflammatory Gr1+ monocyte subset upon liver injury promotes hepatic fibrosis","volume":"50","author":"K R Karlmark","year":"2009","journal-title":"Hepatology"},{"issue":"02","key":"ref96","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.jcmgh.2020.08.012","article-title":"Roles of CCR2 and CCR5 for hepatic macrophage polarization in mice with liver parenchymal cell-specific NEMO deletion","volume":"11","author":"M Bartneck","year":"2021","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"03","key":"ref97","doi-asserted-by":"crossref","first-page":"341","DOI":"10.3390\/cells12030341","article-title":"TREM2 regulates the removal of apoptotic cells and inflammatory processes during the progression of NAFLD","volume":"12","author":"I Liebold","year":"2023","journal-title":"Cells"},{"issue":"35","key":"ref98","doi-asserted-by":"crossref","first-page":"e2405746121","DOI":"10.1073\/pnas.2405746121","article-title":"Lipid-associated macrophages' promotion of fibrosis resolution during MASH regression requires TREM2","volume":"121","author":"S Ganguly","year":"2024","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"ref99","first-page":"e100299","article-title":"Triggering MSR1 promotes JNK-mediated inflammation in IL-4-activated macrophages","volume":"38","author":"M Guo","year":"2019","journal-title":"EMBO J"},{"issue":"05","key":"ref100","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.jhep.2021.12.012","article-title":"Macrophage scavenger receptor 1 mediates lipid-induced inflammation in non-alcoholic fatty liver disease","volume":"76","author":"O Govaere","year":"2022","journal-title":"J Hepatol"},{"issue":"738","key":"ref101","doi-asserted-by":"crossref","first-page":"eadk1866","DOI":"10.1126\/scitranslmed.adk1866","article-title":"Hepatic danger signaling triggers TREM2+ macrophage induction and drives steatohepatitis via MS4A7-dependent inflammasome activation","volume":"16","author":"L Zhou","year":"2024","journal-title":"Sci Transl Med"},{"issue":"02","key":"ref102","doi-asserted-by":"crossref","first-page":"115310","DOI":"10.1016\/j.celrep.2025.115310","article-title":"Lipid droplet efferocytosis attenuates proinflammatory signaling in macrophages via TREM2- and MS4A7-dependent mechanisms","volume":"44","author":"L Zhou","year":"2025","journal-title":"Cell Rep"},{"issue":"01","key":"ref103","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/s42003-024-06357-5","article-title":"Egr2 drives the differentiation of Ly6Chi monocytes into fibrosis-promoting macrophages in metabolic dysfunction-associated steatohepatitis in mice","volume":"7","author":"A Iwata","year":"2024","journal-title":"Commun Biol"},{"issue":"30","key":"ref104","doi-asserted-by":"crossref","first-page":"eado3141","DOI":"10.1126\/sciadv.ado3141","article-title":"Atf3-mediated metabolic reprogramming in hepatic macrophage orchestrates metabolic dysfunction-associated steatohepatitis","volume":"10","author":"S Hu","year":"2024","journal-title":"Sci Adv"},{"issue":"08","key":"ref105","doi-asserted-by":"crossref","first-page":"101488","DOI":"10.1016\/j.jhepr.2025.101488","article-title":"Myeloid TGF-\u03b2 signaling shapes liver macrophage heterogeneity and metabolic liver disease pathogenesis","volume":"7","author":"Z Meng","year":"2025","journal-title":"JHEP Rep"},{"issue":"01","key":"ref106","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.jhep.2025.08.021","article-title":"Cellular senescence in liver diseases: from molecular drivers to therapeutic targeting","volume":"84","author":"K Du","year":"2026","journal-title":"J Hepatol"},{"issue":"02","key":"ref107","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jhep.2024.03.014","article-title":"Phenotypes and ontogeny of senescent hepatic stellate cells in metabolic dysfunction-associated steatohepatitis","volume":"81","author":"C N Yashaswini","year":"2024","journal-title":"J Hepatol"},{"issue":"01","key":"ref108","doi-asserted-by":"crossref","first-page":"15691","DOI":"10.1038\/ncomms15691","article-title":"Cellular senescence drives age-dependent hepatic steatosis","volume":"8","author":"M Ogrodnik","year":"2017","journal-title":"Nat Commun"},{"issue":"01","key":"ref109","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.1038\/s41467-025-57616-w","article-title":"Targeting senescent hepatocytes for treatment of metabolic dysfunction-associated steatotic liver disease and multi-organ dysfunction","volume":"16","author":"K Du","year":"2025","journal-title":"Nat Commun"},{"issue":"04","key":"ref110","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1038\/s43587-026-01101-6","article-title":"p21+TREM2+ senescent macrophages fuel inflammaging and metabolic dysfunction-associated steatotic liver disease","volume":"6","author":"I A Salladay-Perez","year":"2026","journal-title":"Nat Aging"},{"issue":"30","key":"ref111","doi-asserted-by":"crossref","first-page":"eabg5733","DOI":"10.1126\/sciadv.abg5733","article-title":"Disorganization and degeneration of liver sympathetic innervations in nonalcoholic fatty liver disease revealed by 3D imaging","volume":"7","author":"C Adori","year":"2021","journal-title":"Sci Adv"},{"issue":"03","key":"ref112","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.cmet.2021.01.012","article-title":"Metabolic stress drives sympathetic neuropathy within the liver","volume":"33","author":"K Liu","year":"2021","journal-title":"Cell Metab"},{"issue":"12","key":"ref113","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.1038\/s41588-025-02407-8","article-title":"Spatially resolved multi-omics of human metabolic dysfunction-associated steatotic liver disease","volume":"57","author":"Z Li","year":"2025","journal-title":"Nat Genet"},{"key":"ref114","doi-asserted-by":"crossref","first-page":"1705738","DOI":"10.3389\/fimmu.2026.1705738","article-title":"Lipoprotein-associated phospholipase A2 (Lp-PLA2): a key hub linking lipid metabolism and immune inflammation","volume":"17","author":"D Li","year":"2026","journal-title":"Front Immunol"},{"key":"ref115","doi-asserted-by":"crossref","first-page":"e15639","DOI":"10.7717\/peerj.15639","article-title":"Lp-PLA2 silencing ameliorates inflammation and autophagy in nonalcoholic steatohepatitis through inhibiting the JAK2\/STAT3 pathway","volume":"11","author":"J Yao","year":"2023","journal-title":"PeerJ"},{"issue":"06","key":"ref116","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1038\/s41588-026-02600-3","article-title":"Integrated multi-omics identifies distinct macrophage alterations during progression of metabolic dysfunction-associated steatohepatitis","volume":"58","author":"M Boesch","year":"2026","journal-title":"Nat Genet"},{"issue":"09","key":"ref117","doi-asserted-by":"crossref","first-page":"3515","DOI":"10.1073\/pnas.0712381105","article-title":"Interleukin-32 induces the differentiation of monocytes into macrophage-like cells","volume":"105","author":"M G Netea","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"572","key":"ref118","doi-asserted-by":"crossref","first-page":"eaba4448","DOI":"10.1126\/scitranslmed.aba4448","article-title":"Transcriptomic profiling across the nonalcoholic fatty liver disease spectrum reveals gene signatures for steatohepatitis and fibrosis","volume":"12","author":"O Govaere","year":"2020","journal-title":"Sci Transl Med"},{"issue":"10","key":"ref119","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1136\/gutjnl-2019-319226","article-title":"Liver transcriptomics highlights interleukin-32 as novel NAFLD-related cytokine and candidate biomarker","volume":"69","author":"G A Baselli","year":"2020","journal-title":"Gut"},{"issue":"03","key":"ref120","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/s42255-026-01480-5","article-title":"Lipid-dependent accrual of a subset of monocyte-derived macrophages is essential for tissue regeneration","volume":"8","author":"T Yao","year":"2026","journal-title":"Nat Metab"},{"issue":"07","key":"ref121","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nrgastro.2017.38","article-title":"Mechanisms of hepatic stellate cell activation","volume":"14","author":"T Tsuchida","year":"2017","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"03","key":"ref122","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41575-020-00372-7","article-title":"Molecular and cellular mechanisms of liver fibrosis and its regression","volume":"18","author":"T Kisseleva","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"06","key":"ref123","doi-asserted-by":"crossref","first-page":"3498","DOI":"10.4049\/jimmunol.162.6.3498","article-title":"A novel receptor tyrosine kinase, Mer, inhibits TNF-alpha production and lipopolysaccharide-induced endotoxic shock","volume":"162","author":"T D Camenisch","year":"1999","journal-title":"J Immunol"},{"issue":"549","key":"ref124","doi-asserted-by":"crossref","first-page":"eaar3721","DOI":"10.1126\/scisignal.aar3721","article-title":"MerTK signaling in macrophages promotes the synthesis of inflammation resolution mediators by suppressing CaMKII activity","volume":"11","author":"B Cai","year":"2018","journal-title":"Sci Signal"},{"issue":"02","key":"ref125","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1136\/gutjnl-2016-313615","article-title":"MerTK expressing hepatic macrophages promote the resolution of inflammation in acute liver failure","volume":"67","author":"E Triantafyllou","year":"2018","journal-title":"Gut"},{"issue":"02","key":"ref126","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.cmet.2019.11.013","article-title":"Macrophage MerTK promotes liver fibrosis in nonalcoholic steatohepatitis","volume":"31","author":"B Cai","year":"2020","journal-title":"Cell Metab"},{"issue":"04","key":"ref127","doi-asserted-by":"crossref","first-page":"100444","DOI":"10.1016\/j.jhepr.2022.100444","article-title":"Macrophage MerTK promotes profibrogenic cross-talk with hepatic stellate cells via soluble mediators","volume":"4","author":"M Pastore","year":"2022","journal-title":"JHEP Rep"},{"issue":"04","key":"ref128","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1002\/hep.26429","article-title":"Hepatic macrophages but not dendritic cells contribute to liver fibrosis by promoting the survival of activated hepatic stellate cells in mice","volume":"58","author":"J P Pradere","year":"2013","journal-title":"Hepatology"},{"issue":"06","key":"ref129","doi-asserted-by":"crossref","first-page":"e66106","DOI":"10.1371\/journal.pone.0066106","article-title":"The chemokine CCL3 promotes experimental liver fibrosis in mice","volume":"8","author":"D Heinrichs","year":"2013","journal-title":"PLoS One"},{"issue":"07","key":"ref130","first-page":"1858","article-title":"CCR1 and CCR5 promote hepatic fibrosis in mice","volume":"119","author":"E Seki","year":"2009","journal-title":"J Clin Invest"},{"issue":"01","key":"ref131","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jhep.2014.07.035","article-title":"S100A4 promotes liver fibrosis via activation of hepatic stellate cells","volume":"62","author":"L Chen","year":"2015","journal-title":"J Hepatol"},{"issue":"06","key":"ref132","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s00018-022-04319-w","article-title":"Macrophages evoke autophagy of hepatic stellate cells to promote liver fibrosis in NAFLD mice via the PGE2\/EP4 pathway","volume":"79","author":"Y Cao","year":"2022","journal-title":"Cell Mol Life Sci"},{"issue":"27","key":"ref133","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1101\/2025.08.27.671899","article-title":"A human single-cell atlas identifies OLR1+ Scar-associated macrophages as a therapeutic target for chronic liver diseases","volume":"08","author":"E Papachristoforou","year":"2025","journal-title":"bioRxiv"},{"issue":"46","key":"ref134","doi-asserted-by":"crossref","first-page":"E3186","DOI":"10.1073\/pnas.1119964109","article-title":"Differential Ly-6C expression identifies the recruited macrophage phenotype, which orchestrates the regression of murine liver fibrosis","volume":"109","author":"P Ramachandran","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref135","doi-asserted-by":"crossref","first-page":"101989","DOI":"10.1016\/j.molmet.2024.101989","article-title":"Cathepsin D is essential for the degradomic shift of macrophages required to resolve liver fibrosis","volume":"87","author":"P Ruiz-Bl\u00e1zquez","year":"2024","journal-title":"Mol Metab"},{"issue":"03","key":"ref136","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1053\/j.gastro.2023.05.039","article-title":"Macrophage-derived cathepsin S remodels the extracellular matrix to promote liver fibrogenesis","volume":"165","author":"T Zuo","year":"2023","journal-title":"Gastroenterology"},{"key":"ref137","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ebiom.2018.01.028","article-title":"IL-4 receptor alpha signaling through macrophages differentially regulates liver fibrosis progression and reversal","volume":"29","author":"S Y Weng","year":"2018","journal-title":"EBioMedicine"},{"issue":"05","key":"ref138","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1002\/hep.29477","article-title":"A randomized, placebo-controlled trial of cenicriviroc for treatment of nonalcoholic steatohepatitis with fibrosis","volume":"67","author":"S L Friedman","year":"2018","journal-title":"Hepatology"},{"issue":"03","key":"ref139","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1002\/hep.31108","article-title":"Cenicriviroc treatment for adults with nonalcoholic steatohepatitis and fibrosis: final analysis of the phase 2b CENTAUR study","volume":"72","author":"V Ratziu","year":"2020","journal-title":"Hepatology"},{"issue":"01","key":"ref140","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.cgh.2023.04.003","article-title":"Cenicriviroc lacked efficacy to treat liver fibrosis in nonalcoholic steatohepatitis: AURORA phase III randomized study","volume":"22","author":"Q M Anstee","year":"2024","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"01","key":"ref141","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jhep.2020.02.027","article-title":"Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: results from randomized phase III STELLAR trials","volume":"73","author":"S A Harrison","year":"2020","journal-title":"J Hepatol"},{"issue":"05","key":"ref142","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1053\/j.gastro.2019.11.296","article-title":"Effects of belapectin, an inhibitor of galectin-3, in patients with nonalcoholic steatohepatitis with cirrhosis and portal hypertension","volume":"158","author":"N Chalasani","year":"2020","journal-title":"Gastroenterology"},{"issue":"06","key":"ref143","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1056\/NEJMoa2309000","article-title":"A phase 3, randomized, controlled trial of resmetirom in NASH with liver fibrosis","volume":"390","author":"S A Harrison","year":"2024","journal-title":"N Engl J Med"},{"issue":"21","key":"ref144","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1056\/NEJMoa2413258","article-title":"Phase 3 trial of semaglutide in metabolic dysfunction-associated steatohepatitis","volume":"392","author":"A J Sanyal","year":"2025","journal-title":"N Engl J Med"},{"issue":"07","key":"ref145","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/j.cmet.2024.05.003","article-title":"Metabolic reprogramming in liver fibrosis","volume":"36","author":"P Horn","year":"2024","journal-title":"Cell Metab"},{"issue":"04","key":"ref146","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.jhep.2020.04.025","article-title":"Differential effects of selective- and pan-PPAR agonists on experimental steatohepatitis and hepatic macrophages","volume":"73","author":"S Lefere","year":"2020","journal-title":"J Hepatol"},{"issue":"17","key":"ref147","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJMoa2036205","article-title":"A randomized, controlled trial of the Pan-PPAR agonist lanifibranor in NASH","volume":"385","author":"S M Francque","year":"2021","journal-title":"N Engl J Med"},{"issue":"05","key":"ref148","doi-asserted-by":"crossref","first-page":"e1486","DOI":"10.1002\/wsbm.1486","article-title":"The immunologic Warburg effect: evidence and therapeutic opportunities in autoimmunity","volume":"12","author":"M D Kornberg","year":"2020","journal-title":"Wiley Interdiscip Rev Syst Biol Med"},{"key":"ref149","doi-asserted-by":"crossref","first-page":"101634","DOI":"10.1016\/j.redox.2020.101634","article-title":"Annexin A5 regulates hepatic macrophage polarization via directly targeting PKM2 and ameliorates NASH","volume":"36","author":"F Xu","year":"2020","journal-title":"Redox Biol"},{"issue":"14","key":"ref150","doi-asserted-by":"crossref","first-page":"5260","DOI":"10.7150\/ijbs.73890","article-title":"Covalent inhibition of pyruvate kinase M2 reprograms metabolic and inflammatory pathways in hepatic macrophages against non-alcoholic fatty liver disease","volume":"18","author":"N Fan","year":"2022","journal-title":"Int J Biol Sci"},{"key":"ref151","first-page":"189","article-title":"Therapeutic targeting of PKM2 ameliorates NASH fibrosis progression in a macrophage-specific and liver-specific manner","volume":"41","author":"H Qu","year":"2024","journal-title":"Engineering (Beijing)"},{"issue":"48","key":"ref152","doi-asserted-by":"crossref","first-page":"e2410880","DOI":"10.1002\/advs.202410880","article-title":"E2F2 reprograms macrophage function by modulating material and energy metabolism in the progression of metabolic dysfunction-associated steatohepatitis","volume":"11","author":"Z Liu","year":"2024","journal-title":"Adv Sci (Weinh)"},{"issue":"10","key":"ref153","doi-asserted-by":"crossref","first-page":"3823","DOI":"10.7150\/ijbs.96113","article-title":"siRNA-loaded folic acid-modified TPGS alleviate MASH via targeting ER stress sensor XBP1 and reprogramming macrophages","volume":"20","author":"M Zhu","year":"2024","journal-title":"Int J Biol Sci"},{"issue":"04","key":"ref154","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.jhep.2017.05.022","article-title":"Cytotherapy with M1-polarized macrophages ameliorates liver fibrosis by modulating immune microenvironment in mice","volume":"67","author":"P F Ma","year":"2017","journal-title":"J Hepatol"},{"issue":"03","key":"ref155","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1038\/s41591-024-03406-8","article-title":"Autologous macrophage therapy for liver cirrhosis: a phase 2 open-label randomized controlled trial","volume":"31","author":"P N Brennan","year":"2025","journal-title":"Nat Med"},{"issue":"07","key":"ref156","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.stem.2026.04.016","article-title":"Autologous macrophage therapy increases transplant-free survival in cirrhosis: long-term follow-up of a phase 2 clinical trial","volume":"33","author":"P N Brennan","year":"2026","journal-title":"Cell Stem Cell"},{"issue":"06","key":"ref157","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.jhep.2024.01.034","article-title":"Chimeric antigen receptor-modified macrophages ameliorate liver fibrosis in preclinical models","volume":"80","author":"H Dai","year":"2024","journal-title":"J Hepatol"}],"container-title":["Seminars in Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2954-5433.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T22:58:57Z","timestamp":1789513137000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2954-5433"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,15]]},"references-count":157,"URL":"https:\/\/doi.org\/10.1055\/a-2954-5433","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0272-8087","1098-8971"],"issn-type":[{"value":"0272-8087","type":"print"},{"value":"1098-8971","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,15]]}}}